Evidence map›Paper›PMID 24809749›Full record

ArticlePLoS pathogens2014

Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection.

Lukasz Kedzierski, Edmond M Linossi, Tatiana B Kolesnik, E Bridie Day, Nicola L Bird, Benjamin T Kile, Gabrielle T Belz, Donald Metcalf, Nicos A Nicola, Katherine Kedzierska and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Functional Analysis of ZebrafishBrain sciences · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lukasz KedzierskiWalter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Edmond M LinossiWalter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Tatiana B KolesnikWalter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
E Bridie DayDepartment of Microbiology and Immunology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Nicola L BirdDepartment of Microbiology and Immunology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Benjamin T KileWalter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Gabrielle T BelzWalter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Donald MetcalfWalter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Nicos A NicolaWalter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Katherine KedzierskaDepartment of Microbiology and Immunology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Sandra E NicholsonWalter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
University of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

Differentiation of Granulocytes and MacrophagesR37CA022556 · NCI · WALTER AND ELIZA HALL INST MEDICAL RES · PI METCALF, DONALD · 2005 to 2014
$2.3M
DIFFERENTIATION OF GRANULOCYTES AND MACROPHAGESR01CA022556 · NCI · WALTER AND ELIZA HALL INST MEDICAL RES · PI METCALF, DONALD · 1985 to 2004
$900k
NCI NIH HHS R01 CA022556NCI NIH HHS R01 CA22556-26NCI NIH HHS R37 CA022556
6 · The paper itself

Abstract

Suppressor of cytokine signaling (SOCS) proteins are key regulators of innate and adaptive immunity. There is no described biological role for SOCS4, despite broad expression in the hematopoietic system. We demonstrate that mice lacking functional SOCS4 protein rapidly succumb to infection with a pathogenic H1N1 influenza virus (PR8) and are hypersusceptible to infection with the less virulent H3N2 (X31) strain. In SOCS4-deficient animals, this led to substantially greater weight loss, dysregulated pro-inflammatory cytokine and chemokine production in the lungs and delayed viral clearance. This was associated with impaired trafficking of influenza-specific CD8 T cells to the site of infection and linked to defects in T cell receptor activation. These results demonstrate that SOCS4 is a critical regulator of anti-viral immunity.

Indexed as

Adaptive ImmunityAnimalsCD8-Positive T-LymphocytesCytokinesCytoprotectionInflammationInflammation MediatorsInfluenza A Virus, H1N1 SubtypeMiceMice, Inbred BALB CMice, Inbred C3HMice, Inbred C57BLMice, TransgenicOrthomyxoviridae InfectionsSuppressor of Cytokine Signaling ProteinsViral LoadCytokinesInflammation MediatorsSOCS4 protein, mouseSuppressor of Cytokine Signaling Proteins

Identifiers

PMID24809749
PMCPMC4014316
OpenAlexW2027149423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.